<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00263</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (5) Incubation conditions. All plates within a given experiment shall be incubated for the same time period. This incubation period shall be for 48&hyph;72 hours at 37  <!-- PJG 0040 degreeslatlong --> &cir;C.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (6) Number of cultures. All plating shall be done at least in triplicate.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (f)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Data and report <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Treatment of results <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Data shall be presented as number of revertant colonies per plate, revertants per kilogram (or liter) of fuel, and as revertants per kilometer (or mile) for each replicate and dose. These same measures shall be recorded on both the negative and positive control plates. The mean number of revertant colonies per plate, revertants per kilogram (or liter) of fuel, and revertants per kilometer (or mile), as well as individual plate counts and standard deviations shall be presented for the test substance, positive control, and negative control plates.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Statistical evaluation. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Data shall be evaluated by appropriate statistical methods. Those methods shall include, at a minimum, means and standard deviations of the reversion data.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Interpretation of results. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) There are several criteria for determining a positive result, one of which is a statistically significant dose-related increase in the number of revertants. Another criterion may be based upon detection of a reproducible and statistically significant positive response for at least one of the test substance concentrations.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) A test substance which does not produce either a statistically significant dose-related increase in the number of revertants or a statistically significant and reproducible positive response at any one of the test points is considered nonmutagenic in this system.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Both biological and statistical significance shall be considered together in the evaluation.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test evaluation. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) Positive results from the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Salmonella typhimurium <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  reverse mutation assay indicate that, under the test conditions, the test substance induces point mutations by base changes or frameshifts in the genome of this organism.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) Negative results indicate that under the test conditions the test substance is not mutagenic in Salmonella typhimurium.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (5)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test report. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In addition to the reporting recommendations as specified under 40 CFR 79.60, the following specific information shall be reported:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            